Genome-Protecting Compounds as Potential Geroprotectors

Ekaterina Proshkina1, Mikhail Shaposhnikov1, Alexey Moskalev1,2,3

  • 1Laboratory of Geroprotective and Radioprotective Technologies, Institute of Biology, Komi Science Centre, Ural Branch, Russian Academy of Sciences, 28 Kommunisticheskaya st., 167982 Syktyvkar, Russia.

Insights

Organisms face DNA damage and mutations throughout life, leading to aging. This review explores compounds that protect the genome, potentially slowing aging and age-related diseases.

Area of Science:

  • Genetics
  • Molecular Biology
  • Gerontology

Background:

  • Genomic instability, caused by DNA damage and mutations, is a key driver of aging and age-related diseases.
  • Early life protective mechanisms decline with age, leading to accumulated damage.
  • Understanding these mechanisms is crucial for developing interventions against aging.

Purpose of the Study:

  • To review strategies for counteracting age-related genomic instability.
  • To analyze the effects of various compounds on genome protection and lifespan.
  • To identify advanced directions for developing selective genome-protecting drugs.

Main Methods:

  • Literature review of studies on trace elements, vitamins, polyphenols, terpenes, phytochemicals, and synthetic drugs.
  • Analysis of data on genome protection mechanisms and lifespan extension in model organisms.
  • Evaluation of the selectivity and hormetic effects of tested compounds.

Main Results:

  • Numerous compounds, including natural products and synthetic drugs, show geroprotective potential.
  • Many compounds increase lifespan in model organisms by protecting the genome.
  • Genome-protecting effects are often non-selective and influenced by hormesis.

Conclusions:

  • Interventions targeting DNA damage prevention, epigenetic regulation, DNA repair, and cellular senescence show promise.
  • The non-selective nature of current agents highlights the need for targeted approaches.
  • Developing selective drugs for genome protection represents a significant future research direction.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.1K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.8K
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
4.8K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.8K
Telomeres and Telomerase02:41

Telomeres and Telomerase

6.7K
Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...
26.4K